ARCHIVES

Advisors approve NCI’s revised plan for $104-million proteomics research program.

This article is from The Cancer Letter archive.

Vol. 31 No. 27 | July 8, 2005

Download PDF Visit The Full Archive

Related Articles

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

AACR, Kellogg’s Co. Sponsor Award

January 5, 1996

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

May 14, 1999

Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8

February 3, 1978

Roche Markets CMV Test in Europe

April 29, 2011